Halozyme Therapeutics, Inc.
HALO Stock News
Latest HALO news
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Zacks Investment Research · Wed, 23 Sep 2026 11:35:39 -0400
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. FTNT, ABBNY, EAT and HALO are some such stocks.
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
Zacks Investment Research · Wed, 23 Sep 2026 06:30:58 -0400
Halozyme Therapeutics (HALO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
PRNewsWire · Thu, 17 Sep 2026 23:20:00 -0400
SAN DIEGO, Sept. 17, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced the pricing of $1.3 billion aggregate principal amount of 1.50% convertible senior notes due 2033 (the "Convertible Notes").
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
PRNewsWire · Wed, 16 Sep 2026 16:30:00 -0400
SAN DIEGO, Sept. 16, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal amount of convertible senior notes due 2033 (the "Convertible Notes").
3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
Zacks Investment Research · Wed, 16 Sep 2026 13:46:07 -0400
Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.
Halozyme Therapeutics, Inc. (HALO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript
Seeking Alpha · Wed, 16 Sep 2026 13:21:40 -0400
Halozyme Therapeutics, Inc. (HALO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript
Halozyme Therapeutics, Inc. (HALO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · Tue, 15 Sep 2026 13:01:38 -0400
Halozyme Therapeutics, Inc. (HALO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Market information is provided for research and visualization and is not investment advice.